Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Distribution of the PRI With or Without Calcium-Channel Blockers
Distribution of the platelet reactivity index (PRI) in patients with or without calcium-channel blocker treatment is shown. The dotted line represents the lower limit of the normal range of the vasodilator-stimulated phosphoprotein assay (69% PRI).
|
